Broker call▲ Bullish for Sun Pharma

Sun Pharma Lerodalcibep Deal: Macquarie Sees Cross-Selling Opportunities, Maintains 'Outperform' Call

1 source · first seen 08:29 29 Sept · updated 08:29 29 Sept

The brief

Written from 1 report · check the source before you trade

Sun Pharma will pursue regulatory approvals in licensed territories where approval has not yet been obtained
Regulatory progress may shape Sun Pharma’s licensed-market opportunities

Pick a tag to see all its stories

1 report · earliest 08:29